Pfizer seeks to expand omicron booster to 5- to 11-year-olds

日本 ニュース ニュース

Pfizer seeks to expand omicron booster to 5- to 11-year-olds
日本 最新ニュース,日本 見出し
  • 📰 KPRC2
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 68%

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11. pfizer booster kprc2 click2houston vaccine

FILE - A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. to children ages 5 to 11.

If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it is time for their booster. Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

KPRC2 /  🏆 80. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
続きを読む »

Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer seeks to expand omicron booster to 5- to 11-year-oldsIf the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
続きを読む »

Pfizer CEO tests positive for COVID for a second timePfizer CEO tests positive for COVID for a second timeAlbert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster.
続きを読む »

Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
続きを読む »

Pfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsPfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsIf the FDA agrees, children would start getting a kid-sized dose of the new omicron-targeted formula.
続きを読む »

Bivalent booster: Pfizer seeks to expand shot to 5- to 11-year-oldsBivalent booster: Pfizer seeks to expand shot to 5- to 11-year-oldsPfizer is asking the FDA to expand use of its updated COVID-19 vaccine booster shot to children ages 5 to 11. The so-called bivalent shot is meant to be more effective against omicron variants of the coronavirus.
続きを読む »



Render Time: 2025-03-06 21:55:49